Oyster Point is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
- Year invested 2019
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website oysterpointrx.com
- Company Status IPO/Public (NASDAQ: OYST)